Pharma BD Deal Intelligence

Kohlberg Kravis Roberts & Co. / PRA International (Genstar Capital)

2013 · Take-Private · $1.3B · Complete

Announcement Sentiment

Positive

KKR acquired PRA International from Genstar Capital for ~$1.3B; later paired with ReSearch Pharmaceutical Services to create larger CRO platform that IPO'd in 2014.

Did it work? Outcome assessment

Strategic verdict

Achieved Stated Rationale

Financial impact

Accretive

Assessment window: 10yr post-close.

Key facts

Announced Jun 24, 2013
Closed Sep 23, 2013
Deal value $1.3B
Deal type Take-Private
Therapeutic area Contract research
Indications Contract research
Key assets Global clinical CRO services (5,300 employees, 80 countries)
Mechanism Outsourced clinical development services

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals